Rheumatoid meningitis: a rare neurological complication of rheumatoid arthritis

Rheumatoid meningitis: a rare neurological complication of rheumatoid arthritis

ObjectiveTo describe the clinical and neuroimaging characteristics of rheumatoid meningitis (RM) in Chinese patients. MethodsThe patients admitted to our hospital with the diagnosis of RM in the past 8 years were retrospectively analyzed. ResultsSix patients with RM were identified among 933 patient...

Full description

Bibliographic Details
Main Authors:	Siyuan Fan, Jiuliang Zhao, Bo Hou, Mange Liu, Jingwen Niu, Yan Zhou, Chenhui Mao, Haitao Ren, Feng Feng, Mengtao Li, Xiaofeng Zeng, Yicheng Zhu, Hongzhi Guan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Immunology
Subjects:	rheumatoid arthritis rheumatoid meningitis immunotherapy tocilizumab (TCZ) neuroimage
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1065650/full

Similar Items

New insights into the pathogenesis and management of rheumatoid arthritis
by: Shangyi Jin, et al.
Published: (2022-12-01)

Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
by: Benucci M, et al.
Published: (2016-03-01)

Dancing with disorder: chorea – an unusual and neglected manifestation of antiphospholipid syndrome
by: Xiaofeng Zeng, et al.
Published: (2024-10-01)

Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study
by: Yu Shi, et al.
Published: (2023-02-01)

Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
by: Chaojun Hu, et al.
Published: (2020-10-01)

Interpretation on the 2022 Chinese Guideline for the Management of Pregnancy and Reproduction in Patients with Systemic Lupus Erythematous
by: TIAN Xinping, et al.
Published: (2023-05-01)

LSO-009 The impact of high-risk antiphospholipid antibodies profile on major organ damage progression in systemic lupus erythematosus: CSTAR multiple prospective cohort study
by: Xiaofeng Zeng, et al.
Published: (2023-07-01)

LSO-073 Improvements and challenges of systemic lupus erythematosus associated pulmonary arterial hypertension: a 10-year multicenter cohort study
by: Xiaofeng Zeng, et al.
Published: (2023-07-01)

LP-188 Glucocorticoids withdrawn in systemic lupus erythematosus patients with serologically active clinically quiescent state: a desirable goal
by: Xiaofeng Zeng, et al.
Published: (2023-07-01)

Rheumatoid meningitis in the absence of rheumatoid arthritis: 2 cases
by: Juan Yang, et al.
Published: (2024-07-01)

Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis
by: Nan Jiang, et al.
Published: (2023-10-01)

Bone mineral density and microarchitecture among Chinese patients with rheumatoid arthritis: a cross-sectional study with HRpQCT
by: Shangyi Jin, et al.
Published: (2021-04-01)

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)

Update on tocilizumab in rheumatoid arthritis: a narrative review
by: Simone Parisi, et al.
Published: (2025-02-01)

The clinical characteristics of Chinese Takayasu’s arteritis patients: a retrospective study of 411 patients over 24 years
by: Jing Li, et al.
Published: (2017-05-01)

Rheumatoid meningitis sine arthritis: An emerging cause of isolated pachymeningitis and leptomeningitis with typical features
by: Mickael Bonnan, et al.
Published: (2024-09-01)

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
by: Han Joo Baek, et al.
Published: (2019-07-01)

Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis
by: Hanxiao You, et al.
Published: (2020-01-01)

LO-035 The effects and molecular mechanisms of TRAF5 on pulmonary artery endothelial cells in patients with systemic lupus erythematosus associated pulmonary arterial hypertension
by: Xiaofeng Zeng, et al.
Published: (2023-07-01)

Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored
by: Can Huang, et al.
Published: (2022-09-01)

Efficacy of Rituximab on Rheumatoid Leptomeningitis as the First Symptom of Rheumatoid Arthritis
by: Mickaël Chouk, et al.
Published: (2021-04-01)

Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147
by: Devy Zisman, et al.
Published: (2021-12-01)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
by: Siting Li, et al.
Published: (2023-04-01)

Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients
by: Jing Li, et al.
Published: (2020-12-01)

The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines
by: Yutong Li, et al.
Published: (2024-05-01)

Interpretation on the 2024 Chinese Guidelines for the Diagnosis and Treatment of Rheumatoid Arthritis
by: JIANG Nan, et al.
Published: (2024-12-01)

Bone-sparing effects of tocilizumab in rheumatoid arthritis: a monocentric observational study
by: Suhel Gabriele Al Khayyat, et al.
Published: (2022-11-01)

Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis
by: Shangyi Jin, et al.
Published: (2017-11-01)

Rheumatoid Meningitis Presenting With Acute Parkinsonism and Protracted Non-convulsive Seizures: An Unusual Case Presentation and Review of Treatment Strategies
by: David Pellerin, et al.
Published: (2019-02-01)

Prediction of progressive fibrosing interstitial lung disease in patients with systemic sclerosis: insight from the CRDC cohort study
by: Xiaofeng Zeng, et al.
Published: (2024-02-01)

Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome
by: Yongfa Huang, et al.
Published: (2022-07-01)

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
by: Rossella Talotta, et al.
Published: (2018-06-01)

Programmed Cell Death Pathways in the Pathogenesis of Idiopathic Inflammatory Myopathies
by: Jia Shi, et al.
Published: (2021-11-01)

Secondary Normal-Pressure Hydrocephalus in Rheumatoid Meningitis
by: Micaela Owens, et al.
Published: (2021-07-01)

Tocilizumab in rheumatoid arthritis‐associated peripheral ulcerative keratitis: A 1‐year follow‐up case report
by: Jia Huang, et al.
Published: (2022-03-01)

A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: treatment period 2 analysis (week 24 to week 48)
by: Xiaomei Leng, et al.
Published: (2024-09-01)

ANEMIA IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: D A Belenky, et al.
Published: (2012-05-01)

Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
by: Dimitrios A. Pappas, et al.
Published: (2020-03-01)

Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice
by: Dimitrios A. Pappas, et al.
Published: (2019-06-01)

New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)
by: Evgeniy L'vovich Nasonov, et al.
Published: (2010-05-01)